Li Kui Or Li Gui? Investigation Of "Genuine And Fake Hot Spots" In Pharmaceutical Sector

In the face of the epidemic, antiviral, mask, disinfectant, Shuanghuanglian, gilid suppliers, blood products and other sectors, and sometimes triggered a wave of trading tide, the steady state of the original medicine stocks was quickly broken.

Since the Spring Festival, as of February 14th, the biopharmaceutical index rose by 3.79% in just ten trading days.

According to incomplete statistics of twenty-first Century economic report, nearly 1/3 of the listed companies whose stock price has risen more than 20% since February has been involved in the fight against epidemic related masks, disinfectants, anti-virus, medical solid waste disposal, blood products or other drug production.

"We compared the trend of A shares during the" SARS "period, and the pharmaceutical industry did show a more resilient performance, and achieved a period of excess returns in the severe phase of the epidemic. A strategist at a medium-sized brokerage firm in Shanghai said.

Why is the "risk avoiding risk" turning into a hot spot for "hot money dancing"?

Our reporter understands that the trend of more and more pharmaceutical stocks deviates from fundamentals. There are many fish in the mix. There are nearly few junk stocks that have fallen short of face value.

Li Kui or Li Gui?

In the latest February 13th evening, state owned small news announced that the Chinese Medicine carried out the preparation of the new crown virus special plasma products and special immunoglobulin, and successfully prepared the special plasma for clinical treatment.

Early in the morning, the medical sector, which was briefly adjusted, was again boiling under the guidance of blood products.

Wei Guang biology, Tiantan biology, egg laying organisms went straight to the limit.

This is just a silhouette of the A stock market in recent days.

Every time there is new progress in the epidemic, the pharmaceutical sector will emerge in a subdivision area, "striker".

According to the twenty-first Century economic report reporter statistics, in the early days of the outbreak, the concept of anti epidemic and anti virus came to the forefront. The eight consecutive trading days, such as Lu Kang medicine, a well-known antibiotic, and tetracyclic organisms producing pneumonia diagnostic reagents, were trading on a daily basis.

Subsequently, medical devices, diagnostic reagents, disinfectant and other protective supplies were relayed, and pharmaceutical stocks entered a new climax in the battle of epidemic prevention and control. The carnival even spread to the chemical industry of light industrial textile and production disinfectant producing masks.

There must be brave men under the heavy reward. Investors who sniff out business opportunities begin to look for hot spots related to "prevention and control" all over the world.

Over the past time, masks have been rising once and for all, becoming the consensus in the market.

First, the valuation of listed companies such as Ogilvy medical, vibration medical and other major industries and masks protection skyrocketed. Subsequently, the number of "laymen" who had a small share of fortune, such as fortune shares, Hanwang Technology and walkers, also rebounded strongly. Even the temporary new masks production line, such as industrial Fu Lian and SAIC, have ushered in huge amounts of money.

Behind it, Dongguan's Air Conditioner Co., Ltd., which has a mask business under its rovers, lost 27 million 674 thousand yuan in 2018. In 2019, it lost 8 million 806 thousand and 400 yuan in the report. On the interactive platform, Fu Neng shares emphasized that the main business of the company is power, and the South Textile new material related to the production of sanitary disinfectant wipes and non-woven fabrics and masks does not have a significant impact on the company's performance.

The stock price rose 33.58% during the year, and Hanchuan intelligent, which once reached the highest price of 72 yuan, also announced that although the company had masks production equipment business, it accounted for less than 2% of the company's revenue last year.

The hot spot of mask has not yet been extinguished, and new hot spots have been generated.

Without mentioning the "Shuanghuanglian" which caused the mockery of the medical profession, Reed, Xili, the "God drug" widely disseminated during the epidemic period, pushed the A shares of a group of Geely suppliers to the spotlight.

Since February 2nd, it was reported that the drug "Reed Xi Wei" of the American pharmaceutical company jilid was found to be effective after the new coronavirus was found. Yongtai technology, Jiuzhou pharmaceutical, Boteng shares, and Medici and other listed companies have "disclosed" the cooperative relationship between the company and Gillie in the interactive platform or announcement.

"Disclosure" is the most common way for A share companies to post hot spots.

Yongtai technology, Jiuzhou pharmaceutical and even even bluntly, is seeking to cooperate with jilid in the future procurement of drugs Reed Xi Wei intermediate, two listed companies as expected, there are 5 or 3 daily limit.

However, up to now, the biggest winner is Hua Luo Rui medicine. In February 11th, the company announced that it had successfully developed the Reed synthesis technology and preparation technology of raw materials. Subsequently, it has surged for three consecutive trading days, and has gained nearly 80% since February.

But as of now, due to the unclear results of clinical trials, the market is still controversial about the efficacy of Reed's Wei Wei. Insiders predict that the estimated cost of 15 million yuan investment, or in vain.

With the epidemic prevention and control slowly moving forward, a new round of hot spots again and again, this time the lens is directed at blood products......

In February 14th, *ST creatures, who were struggling to survive in the shell battle, welcomed the third daily limit after the festival.

The chairman of the company, the general manager and the certificate generation successively resigned. They suffered losses for two consecutive years. The net assets of the audited end of 2018 were negative. In 2019, the listed companies that only failed to sell their shares through the sale of subsidiaries were constantly jumping in the hot wheels of the pharmaceutical sector.

Reduction of wind four

According to the twenty-first Century economic report reporter survey, along with the valuation of the pharmaceutical sector is rising, a huge cut leek feast is lurking.

Some of the shareholders of listed companies benefited from the surge in share prices.

As early as February 4th ~5, Tai Long pharmaceutical, Yiling pharmaceutical, Lok Xin medical and other epidemic concept stocks issued a notice of major shareholder reduction plan.

Among them, Lok Xin medical is the actual controller plan reduction, and the proportion of shares to be reduced is 4%.

Subsequently, daoen shares, Ying Ke medical, Shang Rong medical and other popular masks shareholders began to be eager.

During the period of rising share price, three real controllers of Shang Rong medical company have reduced 7 million 641 thousand and 600 shares since late January, accounting for 1.04% of the total share capital of the company. During the same period (from January 21st to February 11th), the price of Rong Shang medical company rose 49.79%.

According to the company's actual control of the pre reduction plan, the actual controller in the next three months, there are still 13 million 537 thousand and 400 shares of space can be reduced.

In addition, since February, Ying Ke medical shareholder, Shenzhen Venture Capital and Zibo innovation, which has risen 41.30% over the past year, has also issued a notice of reduction. The proposed reduction will not exceed 7 million 932 thousand shares. Han Limei, one of the real controllers of Daun share, and two senior executives, will jointly reduce their holdings by no more than 13 million 270 thousand and 900 shares, corresponding to the total market capitalization of the late February 14th closing price of about 260 million yuan. Since January 23rd, Daun shares have risen 71.12%.

This is no exception.

According to incomplete statistics of the twenty-first Century economic report, nearly 8 Anti Japanese listed companies have increased their stock price by more than 20% since February. At least 8 shareholders of listed companies have issued a reduction plan or a reduction announcement.

In addition, there are many pharmaceutical stocks after the crazy rise in the early stage, because of shareholders' reduction behavior and crazy callback, therefore is not listed on the list mentioned above.

Recently, Baer, a subsidiary of the company, was identified as "the necessary material production enterprise for epidemic prevention and control". It approved the early resumption of work to ensure the production of medical masks, sanitary wipes, disinfectants and other epidemic prevention and control materials.

Affected by this news, since the beginning of 2020, the price of the song song stock has risen all the way, and for a short period of more than a month, the increase has been over 50%. However, since February 3rd, the major shareholder of the song song stock company has been reducing all the way.

In February 10th, Yang Jianxin announced that the largest shareholder, Shanxi, had reduced 3.2% of its shares from January 17, 2020 to February 6th. After the reduction, Yang Jianxin was no longer the largest shareholder of the company. The second largest shareholder, Guang Jia Hui Management Consulting Co., Ltd., became the largest shareholder of the company. Subsequently, the trend of Qing song stock is a great drain.

In addition to rubbing hot spots, "cutting leeks", more enterprises were originally on the edge of the explosion, but also because the "hype" to turn the corner.

For example, due to cross-border setbacks, controlling shareholder capital chain tension and environmental remediation and other factors, one of the beneficiaries of this theme speculation is the continued downturn in share prices and state biology.

In the first trading day after the Spring Festival, thousands of shares fell to the bottom of the stock market, and Bong also welcomed the lowest point of stock price - 1.32 yuan, which allowed the high proportion of the controlling shareholders and the state group to face the enemy. On the night of February 3rd, the company announced that part of the shareholding pledge of the controlling shareholder was extended.

As of the evening of February 3rd, the total number of shares held by Ho Bang Group was 2 billion 493 million shares, accounting for 28.23% of the total share capital of the company, while the total number of shares pledged was 2 billion 340 million shares, accounting for 93.85% of its total holdings.

As the epidemic raged, the demand for disinfectant rose sharply, and the production of sodium hypochlorite products and state biology welcomed the turning point. Stock prices began to rise sharply, lifting the urgent need of controlling shareholders at one stroke.

How far can a drum flower pass?

The trend of the pharmaceutical sector is becoming more and more chaotic, and there is an endless stream of subject shares and hot spots. Even though there are some enterprises whose performance is expected to meet expectations, the valuation is already breaking away from fundamentals in high school.

"In the near future, we must not pursue medicine stocks, hype too much, and the valuation is obviously high. These days have begun to adjust." In February 13th, a senior investor in Southern China pointed out that

Behind the well-known anti epidemic concept stocks, such as Da'an gene, unnamed medicine, and Yue Yue medical treatment, all kinds of capital "push hands" emerge one after another.

In the early days before the Spring Festival, many of the sensitive funds were hidden in the concept of virus control.

As early as in January 23rd, the industry called "Shanghai super short Gang" the top hot money Guotai Junan Shanghai new gate road quickly bought fish diving medical treatment 20 million 999 thousand and 900 yuan, then, fish diving medical treatment for four consecutive trading days, the share price is red.

The drama of the right and left is also staged.

During the epidemic, the new type of coronavirus (2019-nCoV) nucleic acid detection kit was detonating Da an gene, and its regular list was regular.

Behind it, Dongfang Fortune Securities Lhasa East Ring Road second securities business department (referred to as "Oriental Wealth Lhasa East Ring Road") and the Oriental Wealth securities Lhasa unity Road second securities business department (referred to as "Oriental Wealth Lhasa unity Road") several times at the same time the top five seats in the company.

In February 7th and February 10th, the eastern fortune Lhasa unity Road two played with the "buy and sell" drama. In February 7th, it sold 16 million 823 thousand and 100 yuan at the time of buying 16 million 474 thousand and 900 yuan, ranking third buying seats and second big selling seats on the day, and buying 38 million 869 thousand and 700 yuan and selling 47 million 442 thousand and 500 yuan in February 9th, respectively. Seat.

At the same time, the Oriental Wealth Lhasa unity Road also appeared in the list of tiger list of unnamed medicine, Shen Lian biology and jent biology.

On the same day in February 14th, the daily eggs were sold as seats on the tiger list. The top 5 buyers bought a total of 56 million 418 thousand and 100 yuan, accounting for 46.59% of the total turnover of the day, while the agencies sold 25 million 972 thousand and 500 yuan in one fell swoop.

It is worth mentioning that, in recent days, pharmaceutical stocks have begun to cool down significantly, the masks index has dropped four, this week, the cumulative decline of 11.7%, medical devices fell 4.75% this week, chemical pharmaceutical week fell 2.09%.

?